The Discounted Cash Flow (DCF) valuation of Transmedics Group Inc (TMDX) is 97.00 USD. With the latest stock price at 86.40 USD, the upside of Transmedics Group Inc based on DCF is 12.3%.
Based on the latest price of 86.40 USD and our DCF valuation, Transmedics Group Inc (TMDX) is a buy. buying TMDX stocks now will result in a potential gain of 12.3%.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.0% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 59.62 - 223.17 | 97.00 |
| Upside | -31.0% - 158.3% | 12.3% |